lpca Laboratories and Omexa Formulary join forces to develop anti-cancer biosimilar
lpca Laboratories Ltd. (lpca) has embarked on a collaboration with Omexa Formulary Pvt. Ltd. (Omexa), through a Technology Transfer Agreement aimed at fostering the development of an anti-cancer biosimilar for the global market. This strategic partnership grants Omexa non-exclusive rights to research, develop, manufacture, and market the biosimilar, marking a significant step in the fight […]